Ampliphi $18M round sets stage for bacteriophage
With the goal of delivering early clinical data over the next 18 months to demonstrate the validity of its scientific approach and move from the pink sheets to a registered exchange, Ampliphi Biosciences Corp. inked agreements with a group of investors for an $18 million private placement.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter